Dorsey & Whitney Trust CO LLC Has $719,000 Stock Holdings in Agilent Technologies, Inc. $A

Dorsey & Whitney Trust CO LLC boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 9.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,093 shares of the medical research company’s stock after purchasing an additional 540 shares during the quarter. Dorsey & Whitney Trust CO LLC’s holdings in Agilent Technologies were worth $719,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of A. Stone House Investment Management LLC bought a new stake in shares of Agilent Technologies during the 1st quarter worth about $30,000. Ransom Advisory Ltd bought a new stake in shares of Agilent Technologies during the first quarter worth approximately $32,000. Central Pacific Bank Trust Division acquired a new position in shares of Agilent Technologies in the second quarter valued at approximately $33,000. Zions Bancorporation National Association UT acquired a new position in shares of Agilent Technologies in the first quarter valued at approximately $38,000. Finally, Costello Asset Management INC bought a new position in shares of Agilent Technologies during the first quarter worth approximately $47,000. 87.41% of the stock is owned by institutional investors.

Agilent Technologies Stock Down 0.5%

A stock opened at $143.86 on Wednesday. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84. The business has a 50-day simple moving average of $138.31 and a 200 day simple moving average of $124.52. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The company has a market cap of $40.78 billion, a PE ratio of 33.77, a price-to-earnings-growth ratio of 4.67 and a beta of 1.29.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the firm earned $1.32 EPS. The business’s quarterly revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th were paid a dividend of $0.248 per share. The ex-dividend date was Tuesday, September 30th. This represents a $0.99 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is presently 23.24%.

Insider Buying and Selling at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 12,490 shares of Agilent Technologies stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the transaction, the chief executive officer owned 33,448 shares in the company, valued at approximately $5,017,200. This trade represents a 27.19% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.26% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Evercore ISI boosted their price target on Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research note on Tuesday, October 7th. Rothschild & Co Redburn assumed coverage on shares of Agilent Technologies in a research report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price for the company. Robert W. Baird upped their price target on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research note on Thursday, August 28th. JPMorgan Chase & Co. raised their price target on shares of Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Finally, Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $149.62.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.